A comprehensive view of epidemic / pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF"
Published:
September 11, 2024
by U.S. Fed News
|
Swissmedic grants full marketing authorization for updated COVID-19 vaccine targeting JN.1 variant; vaccination recommended in autumn for high-risk individuals in Switzerland
Published:
September 11, 2024
by Industry Intelligence Inc.
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ACE2-IGM-FC FUSION PROTEINS AND USES THEREOF"
Published:
September 11, 2024
by U.S. Fed News
|
Intergovernmental Negotiating Body meets in Geneva for 11th session; IFPMA advocates for flexible Pandemic Agreement recognizing industry diversity
Published:
September 09, 2024
by International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
|
NH HB1485: Establishes a committee to study the circumstances surrounding the COVID-19 pandemic and government responses.
Published:
September 09, 2024
by New Hampshire 2024 Regular Session
|
Ask us about our Sustainability & Social Responsibility market view